Curated Information
Javascript is not enabled on this browser. This site will not work properly without Javascript.
PhosphoSitePlus Homepage PhosphoSitePlus® v6.6.0.1
Powered by Cell Signaling Technology
Home > Curated Information Page > PubMed Id: 27358484
Nebbioso A, et al. (2017) c-Myc Modulation and Acetylation Is a Key HDAC Inhibitor Target in Cancer. Clin Cancer Res 23, 2542-2555 27358484
This page summarizes selected information from the record referenced above and curated into PhosphoSitePlus®, a comprehensive online resource for the study of protein post-translational modifications (NAR, 2015, 43:D512-20). To learn more about the scope of PhosphoSitePlus®, click here.
Click on the protein name to open the protein page, and on the RSD number to open the site page.

K323-ac - Myc (human)
Modsite: RkDYPAAkRVkLDsV SwissProt Entrez-Gene
Orthologous residues
Myc (human): K323‑ac, Myc iso2 (human): K338‑ac, Myc (mouse): K323‑ac, Myc (rat): K323‑ac
Upstream Regulation
Treatments, proteins and their effect on site modification: 
Treatments Referenced Treatments Manipulated Protein Referenced Protein Effect Notes
vorinostat increase
selisistat no change compared to control
MS275 increase